PHASE II/III, PLACEBO CONTROLLED STUDY OF SNX-111 ADM.INTRATHECALLY TO PAIN PTS

SNX-111 ADM 鞘内注射治疗 PTS 疼痛的 II/III 期安慰剂对照研究

• 批准号: 6219369
• 负责人: DONALD R STANSKI
• 金额: $ 0.06万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6219369
• 关键词: analgesics; chronic pain; clinical research; drug administration routes; drug screening /evaluation; human subject; human therapy evaluation; neuropathology; neuroprotectants; pain; placebos

The study was designed to test the efficacy of SNX-111 in non-cancer chronic pain patients. Generally, neuropathic pain states were chosen for study as more traditional therapeutic options are generally ineffective for this disease.

该研究旨在测试SNX-111在非癌症慢性疼痛患者中的疗效。通常，选择神经性疼痛状态进行研究，因为更传统的治疗选择通常对这种疾病无效。